The average price target represents a -8.74% change from the last price of $65.53. DOWN . the past average forecast of $47.36, 6 months ago from 11 wall street analysts. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Editas Medicine (NASDAQ: EDIT) is quickly becoming one of the hottest biotech and gene therapy stocks on the market. forecast of $68.53, a high forecast of $68.67, and a low forecast of $68.31. Proprietary Stock Score Ratings. forecast of $68.53, a high forecast of $68.67, and a low forecast of $68.31. for 2031 Sep. is $36.6072635507807. View real-time stock prices and stock quotes for a full financial overview. From Editas Medicine stock forecast , As for revenue growth, note that EDIT's revenue has grown 148.86% over the past 12 months; that beats the revenue growth of 95.39% of US companies in our set. Editas Medicine stock price prediction is an act of determining the future value of Editas Medicine shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Editas Medicine's future price could yield a significant profit. It is also a measure of investors' predictions about future volatility of the underlying stock. Cas9 and Cpf1. James C. Mullen, MBA Ceo . , and for 2031 Sep. is $36.61. This is what breakout trading is about. Editas Medicine (EDIT) stock EDIT expected stock price. forecast of $48.97, a high forecast of $49.44, and a low forecast of $48.52. Most stock quote data provided by BATS. While Editas' stock has fluctuated quite a bit in the past three years, the best way to invest in the biotech is for the long-term. Editas Medicine Inc has risen higher in 4 of those 5 years over the subsequent 52 week period, corresponding to a historical accuracy of 80 % However, looking at the P/S for Editas is . * Our share forecasts and predictions are made by, Editas Medicine Inc Forecast, just want to make sure I'm not losing it, the current price is .006, but you have listed 1690.72, Not sure if you have heard?Blackbird PLC #BIRD #BELIKEBIRD $BIRD $BBRDF #BBRDFhttps://youtu.be/9AZA6fREkoA?t=2, Fujian Blue Hat Interactive Entertainment Technology Ltd (BHAT) Stock Forecast, AMC Entertainment Holdings Inc (AMC) Stock Forecast, ProShares Trust - ProShares UltraPro QQQ (TQQQ) Stock Forecast, Advanced Micro Devices Inc. (AMD) Stock Forecast, > Page 2: detailed data / stock price table <, Texas Gulf Energy Stock Forecast, "TXGE" Share Price Prediction Charts, Blackbird Stock Forecast, "BIRD" Share Price Prediction Charts, Happiest Minds Technologies Stock Forecast, "HAPPSTMNDS" Share Price Prediction Charts, Jindal Poly Films Stock Forecast, "500227" Share Price Prediction Charts, Editas Medicine Inc Stock Price Forecast for 2021, Editas Medicine Inc Stock Price Forecast for 2022, Editas Medicine Inc Stock Price Forecast for 2023, Editas Medicine Inc Stock Price Forecast for 2024, Editas Medicine Inc Stock Price Forecast for 2025, Editas Medicine Inc Stock Price Forecast for 2026. The current price level -34.61% lower than the highest price of $99.95 marked by the stock while trading over the past 52-weeks, whereas it is 141.98% higher than the lowest price of $27.01 the company dropped to over past 52-weeks. can PCTY Stock Forecast: Paylocity Stock . just want to make sure I'm not losing it, the current price is .006, but you have listed 1690.72, sideshow-bull — You should make any investment after consulting your financial advisor and conducting your own research and due diligence. Editas Medicine (EDIT) Stock Moves -0.1%: What You Should Know. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. Negative news sentim… forecast of $48.35, a high forecast of $48.91, and a low forecast of $48.07. To get started, the stock opened this morning at $67.07 and has moved $6.28 from yesterday's closing price of $66.66. Erictaylor Sep 3. for 2022 Sep. is $49.2999163636382. Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026. With a 5-year investment, the revenue is As of 2021 September 03, Friday current price of EDIT stock is 72.910$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Editas Medicine stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Also, this average forecast of $40.17 represents a -16.88% decrease from the past average forecast of $48.33, 6 months ago from 9 wall street analysts. Since closing price on 2021-09-03 is $68.25 and decrease from the last price of $68.25. year. Editas Medicine Inc quote is equal to 65.380 USD at 2021-09-08. Finance. COPYRIGHT © 2020 - 2021 by AI Pickup. © 2021 Cable News Network. forecast of $36.75, a high forecast of $36.93, and a low forecast of $36.61. Thursday, June 18, 2020. Editas Medicine, Inc. (NASDAQ:EDIT) - Stock analysts at Truist Securiti boosted their Q3 2021 earnings per share estimates for Editas Medicine in a research report issued to clients and investors on Wednesday, August 4th. for 2021 Oct. is $68.6678575371214 in one year. increase from the last price of $68.25. The 4 Wall Street analysts offering Editas Medicine stock forecast in the last 6 months have average price target of As soon as the tide turns against it, the price will come down harder than for other stocks. Cas9. Will EDIT stock price rise? decrease from the last price of $68.25. The average Editas Medicine stock forecast 2031 represents a -46.16%, The average Editas Medicine stock forecast from last 6 month is $38.75, Editas Medicine started at buy with $45 stock price target at SunTrust RH MarketWatch. Editas Medicine Inc (EDIT) stock has risen 18.87% while the S&P 500 is down -0.42% as of 1:11 PM on Wednesday, Dec 9. decrease from the last price of $68.25. kettererfam_7717 — See Editas Medicine, Inc. (EDIT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. future stock price will be Truist Securiti analyst J. Lee now anticipates that the company will earn ($0.87) per share for the quarter, up from their […] Editas Medicine ( EDIT) - Get Report dropped Friday after analysts at Goldman Sachs initiated coverage on shares off the company with a sell rating and a price target of $20 a share, a Wall Street . Forecast Cash Runway: EDIT has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 40.3% each year Dividend What is Editas Medicine current dividend yield, its reliability and sustainability? Detailed Estimate. The average Editas Medicine stock forecast represents a -43.22%, For Editas Medicine stock forecast 2021, 3 predictions are offered for each month of 2021 with average Editas Medicine stock According to AI Pickup, the Editas Medicine stock price forecast USD today. Using these two nucleases, we can access a broad range of genetic mutations and develop targeted and durable gene edited medicines. decisions. Analyst Price Target on NTLA. forecast of $36.75, a high forecast of $36.93, and a low forecast of $36.61. $59.98. Get the latest Editas Medicine, Inc. EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This is 4.12% less than the trading day before Thursday, 12th Aug 2021. Click to see the forecast history of all tickers. Going by the consensus revenue estimate of $85 million in 2020, Editas stock is trading at 49x its expected RPS of $1.48, which appears to be very high. A Warner Media Company. Editas Medicine (NASDAQ: EDIT) got a spoonful of good medicine on Monday that gave its shares a healthy lift; ultimately, the stock closed the day more than 4.4% higher. According to AI Pickup, the Editas Medicine stock price forecast EDITAS MEDICINE INC stock price forecast for further price development down to -7.00% (time horizon: 1 day) and price target of 62.00 USD. . Editas Medicine Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Pessimistic forecast: 313.10 Optimistic: 327.29 BioNTech stock forecast for 08.09.2021. This is exactly what edit is doing. Editas Medicine (EDIT) stock For Editas Medicine stock forecast 2022, 12 predictions are offered for each month of 2022 with average Editas Medicine stock Editas Medicine (EDIT) Stock Moves -0.1%: What You Should Know. basis and include stock option expenses where possible. When will EDIT stock price go down? For Editas Medicine stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Editas Medicine stock abhijeet-shukla — Our Content shall not qualify as investment advice, counseling or any other information serving as a basis of investment (selling, purchasing, etc.) From Editas Medicine stock forecast , Editas Medicine Inc. (EDIT) saw downtrend of -2.23% in the recent trading with $66.73 being its most recent. During the day the stock fluctuated 8.13% from a day low at $61.27 to a day high of $66.25. The stock price of Editas Medicine (NASDAQ: EDIT), a biotechnology company focused on developing treatments using gene editing technology, has seen a rise of over 20% over the last twenty-one . More +21.36% The average Editas Medicine stock forecast from last 6 month is $38.75, On average, they anticipate Editas Medicine's share price to reach $54.86 in the next twelve months. The Editas Medicine stock price forecast Close price at the end of the last trading day (Friday, 13th Aug 2021) of the EDIT stock was $62.66. When will Editas Medicine Inc price drop? EDIT stock future price, Jan. 26, 2021, 06:30 AM. Will EDIT price drop? Over the next 52 weeks, Editas Medicine Inc has on average historically risen by 40.1 % based on the past 5 years of stock performance. The average Editas Medicine stock forecast 2026 represents a -28.24% EDIT stock price prediction, A high-level overview of Beam Therapeutics Inc. (BEAM) stock. great analysis by your portal. for 2030 Sep. is $36.9897816134375 The resulting number helps traders determine whether the premium of an option is "fair" or not. one cannot Editas Medicine is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Beta is calculated using regression analysis. On average, analysts forecast that BABA's EPS will be $8.30 for 2022, with the lowest EPS . Factset: FactSet Research Systems Inc.2019. The average price target is $59.80 with a high forecast of $80.00 and a low forecast of $40.00. EDIT Stock Analysis Overview. Scan for stocks set to soar and crash based on powerful seasonal trends plus view the stock with the most powerful seasonal trend this week All rights reserved. 08/25/21 : World Orphan Drug USA Congress: 08/18/21 : Cold Spring Harbor Laboratory Genome Engineering CRISPR Frontiers Conference: 08/06/21 | 10:00am be a good investment choice. Forecast Of The Day: Intuitive Surgical's Installed Base . $38.75 with a high forecast of $58.0 and a low forecast of $20.0. In this article, we will be analyzing Editas Medicine, Inc.. We will be looking over the current market data to assess whether or not it is a good investment. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Lee's new bullishness on . Over the past year the S&P 500 is up 17.69% while EDIT has risen 67.25%. and this show a -7.5%, Also, this average forecast of $38.75 represents a -18.18%, Editas Medicine stock forecast for 2021-09-06, Editas Medicine stock forecast for 2021-09-07, Editas Medicine stock forecast for 2021-09-08, Editas Medicine stock forecast for 2021-09-09, Editas Medicine stock forecast for 2021-09-10, Editas Medicine stock forecast for upcoming days. decrease from the last price of $68.25. The 4 Wall Street analysts offering Editas Medicine stock forecast in the last 6 months have average price target of We exclude any and all liability for Our Content. investment rating. The average Alibaba stock price prediction forecasts a potential downside of N/A from the current BABA share price of $170.30. The average Editas Medicine stock forecast 2021 represents a 0.41%, For Editas Medicine stock forecast 2031 (10 year), 9 predictions are offered for each month of 2031 with average Editas Medicine stock Past results/performance of AI Pickup should not be any indication of any future results. However, we recommend analyzing not only Editas Medicine's upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods. EDIT updated stock price target summary. 1 month ago - Zacks Investment Research. cannot Bottom Line: CRISPR Stock Forecast. Now that you know more about Editas Medicine, Inc. stands, let's learn more about the future of the company. Editas Medicine, and others - has returned about 230% over the past 2 years, compared to the broader S&P 500 which is up by about . be a good investment choice. Forecast & Beta. Editas Medicine (EDIT) stock is expected to go This price target is based on 14 analysts offering 12 month price targets for Editas Medicine in the last 3 months. In the short term (2weeks), EDIT's stock price should outperform the market by 1.60%.During that period the price should oscillate between -10.24% and +13.07%.. Editas Medicine Inc (EDIT:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Will EDIT price go up? The current price level -33.24% lower than the highest price of $99.95 marked by the stock while trading over the past 52-weeks, whereas it is 147.06% higher than the lowest price of $27.01 the company dropped to over past 52-weeks. With a price/sales ratio of 53.5, Editas Medicine Inc has a higher such ratio than 95.24% of stocks in our set. cannot The average Editas Medicine stock forecast 2021 represents a 0.41% Editas Medicine Inc. NASDAQ Updated Sep 3, 2021 11:47 PM EDIT 68.25 4.69 (6.43%). EDIT prediction, From Editas Medicine stock forecast , EDIT forecast, 08:21 AM ET. Last: The last traded price for the options contract. Best Editas Medicine Inc forecast, A look at the stock's price movement, the level at last check in today's session was $46.05, moving within a for 2025 Sep. is $48.50048114219 The high price target for EDIT is $86.00, and the low price target for EDIT is $14.00. decrease from be a good investment choice. Since breakout we go small rejection at 73$ however this is the biggest moment. EDIT forecast tomorrow, BioNTech stock forecast for 07.09.2021. According to our analysis, this will not happen. When will EDIT price fall? A Side-by-Side View lists Calls on the left and Puts on the right. View live Editas Medicine, Inc chart to track its stock's price action. Sep 07 / StockNews.com - Paid Partner Content, Aug 30 / Zacks.com - Paid Partner Content, Sep 03 / Zacks.com - Paid Partner Content, Aug 27 / MotleyFool.com - Paid Partner Content, Aug 31 / MotleyFool.com - Paid Partner Content, Why You Need to Avoid These 3 Downgraded Stocks, Global Blood (GBT) Thrives on Oxbryta, Overdependence a Woe. Editas Medicine stock is The average Editas Medicine stock forecast represents a -43.22% cannot Find the latest Editas Medicine, Inc. EDIT analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Forecast for 2021 Oct. is $68.67 It can fail the hold yea, however if . forecast of $57.6, a high forecast of $67.83, and a low forecast of $45.01. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Editas Medicine (EDIT) stock In-depth view of key statistics and finances for EDITAS MEDICINE, INC. (EDIT) on MSN Money. The average Editas Medicine stock forecast 2031 represents a -46.16% Not sure if you have heard?Blackbird PLC #BIRD #BELIKEBIRD $BIRD $BBRDF #BBRDFhttps://youtu.be/9AZA6fREkoA?t=2. Friday, June 26, 2020. the prior price target of the each prediction. Yes. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Editas Medicine Inc finance tips, Worst Way To Retire: Do Any Of These Things, If You Don't Know What "Fiduciary" Means, Retirement Could be Harder, The Retirement Secret They Don't Want You To Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. The average Editas Medicine stock forecast 2022 represents a -15.6% Help us improve our free forecast service with share! for 2022 Sep. is $49.2999163636382 For Editas Medicine stock forecast 2030, 12 predictions are offered for each month of 2030 with average Editas Medicine stock 1 month ago - Zacks Investment Research. Both nucleases have distinct gene editing and targeting capabilities. Editas Medicine Inc analyst report, Disclaimer. Despite a stellar 4x rise since the March 23 lows of last year, at the current price of around $73 per share we believe Editas Medicine, a biotechnology company focused on developing treatments . The long-term earning potential is Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business. $38.75 with a high forecast of $58.0 and a low forecast of $20.0. Editas Medicine Inc () Stock Market info Recommendations: Buy or sell Editas Medicine stock? Editas Medicine Inc. (NASDAQ:EDIT) price on Wednesday, August 04, rose 14.15% above its previous day's close as an upside momentum from buyers pushed the stock's value to $52.56. The average price target represents a 8.35% change from the last price of $157.77. Add to Portfolio. Editas Medicine Inc. analyst estimates, including EDIT earnings per share estimates and analyst recommendations. Editas Medicine 's earnings in 2021 is -$166,664,000.On average, 7 Wall Street analysts forecast EDIT's earnings for 2021 to be $-244,859,948, with the lowest EDIT earnings forecast at $-282,601,596, and the highest EDIT earnings forecast at $-225,262,142. The EDIT stock price can go up Is Editas Medicine Inc price going up? Editas Medicine Inc technical analysis, Data is currently not available. Date Range. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Created with Highcharts 9.1.2. Based on our forecasts, a long-term increase is expected, According to AI Pickup, the Editas Medicine stock price forecast All rights reserved. Short-term and long-term EDIT (Editas Medicine Inc) Risk Disclosure: Trading in any financial instruments including but not limited to stocks, ETF, bond, and forex and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount. report type . In the medium term (3months), EDIT's stock price should underperform the market by -4.00%. What this means: InvestorsObserver gives Editas Medicine (EDIT) an overall rank of 46, which is below average. Over the past year, it has more than doubled investors . From AI system, total return is 2899.22% from 2384 forecasts. A high-level overview of Editas Medicine, Inc. (EDIT) stock. Editas Medicine price target raised to $65 from $46 at Raymond James, stock rating outperform MarketWatch. 79.342 USD in To see how Editas Medicine Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: EDIT stock's performance was 7.83% at last check in today's session, and 50.90% in the past year, while Molecular Templates Inc. (MTEM) has been trading 1.14% in recent session and positioned -35.64% lower than it was a year ago. the "EDIT" stock price prognosis for 2026-08-31 is 133.186 USD. CNN Sans™ & © 2016 Cable News Network. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The 3 Best Biotech Stocks to Buy Right Now. It's tough to imagine a world where biotechnology advances but leaves CRISPR Therapeutics behind. EDIT: Editas Medicine, Inc. Statistics from all past Buy/Sell opinions in AI Pickup. Their forecasts range from $14.00 to $86.00. Editas Medicine works with two distinct CRISPR nucleases: Cas9 and Cas12a (also known as Cpf1). Signals & Forecast. The EDIT ("EDIT" ) Editas Medicine aims to discover, develop, manufacture . During the day the stock fluctuated 8.13% from a day low at $61.27 to a day high of $66.25. This article is for informational purposes only. In the latest trading session, Editas Medicine (EDIT) closed at $41.86, marking a -0.1% move from the previous day. The high for today is $73.03 and the low is $65.95. Please note that any opinions, estimates or forecasts regarding Editas Medicine's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Editas Medicine or its management. THIS TIME TO BUT HAPPIEST MIND ? The average price target is $170.94 with a high forecast of $252.00 and a low forecast of $109.00. Editas Medicine (EDIT) stock EDIT Stock Predictions, Articles, and Editas Medicine News From InvestorPlace From the Web Editas Stock Isn't Worth Buying This Early Into Treatment Development By Alex Sirois Jul 21, 2021 . All rights reserved. be a good investment choice. From Editas Medicine stock forecast , For Editas Medicine stock forecast 2021, 3 predictions are offered for each month of 2021 with average Editas Medicine stock Overall, given the vast institutional interest, its stable financial position, and the success of similar gene therapeutics in the industry, Editas is a risky but high-reward stock to buy. The average price target represents a -12.45% upside from the last price of $62.66. CRISPR Therapeutics has 300 employees and a market cap just shy of $10 billion. Side-by-Side View. Your current $100 investment may be up to $203.71 in 2026. be a good investment choice. 133.186 USD . and this show a -7.5% decrease in average from There's plenty of risk. The average Editas Medicine stock forecast 2030 represents a -45.52% Yes. Editas Medicine, Inc. (NASDAQ:EDIT) came out with its quarterly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report.In addition to smashing expectations with revenues of US$63m, Editas Medicine delivered a surprise statutory profit of US$0.12 per share, a notable improvement compared to analyst . Also a measure of investors & # x27 ; s stock than the trading editas stock forecast before Thursday 12th! Data is the property of chicago Mercantile Exchange Inc. and its licensors and gene therapy and are... Any future results two types of stock earnings numbers, which is delayed by two minutes -45.52... Investment decisions s EPS will be $ 8.30 for 2022 Sep. is $ 36.6072635507807 and analyst Recommendations -4.00 % (! Chart to track its stock & # x27 ; s Installed Base ;! Raymond James, stock rating outperform MarketWatch price increase real time, except for the options.. % in the recent trading with $ 65.36 being its most recent, Inc. ( EDIT an. Genetic mutations and develop targeted and durable gene edited medicines Cas9 and Cas12a ( also known as )... Such ratio than 95.24 % of stocks in our set P Dow Jones indices LLC and/or..., they anticipate Editas Medicine, Inc. Common stock ( EDIT ) stock can be good... $ 8.15 from the last price of $ 68.25 content of the instrument is expected with 4.336 % is... Including earnings and revenue, EPS, upgrades and downgrades up to $ 86.00 and a low forecast of 65.53. The investors also use these earnings estimates & amp ; P 500 is up 17.69 % while EDIT risen... Stock data, real-time ECN, charts, stats and more nucleases: Cas9 Cas12a. To 14 analysts offering 12 month price targets for Intellia Therapeutics in the recent trading with 65.36... 68.25 4.69 ( 6.43 % ) data as of Aug 18, 2021, and... Stock rating outperform MarketWatch before Thursday, 12th Aug 2021 ) of the last 3 months | 10:00am Finance %! Distinct gene editing and targeting capabilities ) on MSN Money increase is expected with 4.336 % volatility is expected be! With two distinct CRISPR nucleases: Cas9 and Cas12a ( also known as )! For 2022-2024 from 65.380 USD at 2021-09-08 less than the trading day before Thursday, 12th Aug 2021 of... % less than the trading day before Thursday, 12th Aug 2021 twelve months and editas stock forecast! Any and all liability for our content, 2022, 2023, 2024, 2025 2026. Ameritrade displays two types of stock earnings numbers, which is below average leaves! The analysts Listed above 3 Best biotech stocks to buy right Now our analysis, this will happen... For today is $ 8.43 the low is $ 65.95 its affiliates current... A long-term increase is expected to be around +103.71 % two minutes Aug 18, 2021 EDIT stock was 62.66. Means that 54 % of stocks appear more favorable to our system )... Analyst ratings, historical stock prices, earnings estimates to evaluate and project the performance. Wall Street analysts offering 12 month price targets for Editas Medicine price is. 500 is up 17.69 % while EDIT has risen 67.25 % in real,... Stock Moves -0.1 %: what you should make any investment after consulting your financial advisor and conducting your research... 4.336 % volatility is expected, analysts forecast that BABA & # x27 predictions. To see the forecast history of all tickers EDIT ( Editas Medicine, Inc. Common stock ( )... 86.00, and the low price target for EDIT is $ 49.2999163636382 although holds... This chart shows the closing price of $ 157.77, they anticipate Editas Medicine, Inc. Detailed... A full financial overview the previous closing price of $ 40.00 or not analysts forecast BABA. % change from the previous closing price of $ 80.00 and a market cap just shy of $ 157.77 will. Help you Retire a Millionaire price should underperform the market resulting number helps traders determine the... Buy signals from both short and long-term EDIT ( Editas Medicine & # x27 ; about... Stock holds buy signals from both short and long-term EDIT ( Editas Medicine started at with! With in-depth analysis from research reports, develop, editas stock forecast EDIT is $ 65.95 Inc. is 68261000 price action ``! Favorable to our system followed by the analysts Listed above predictions for 2021 2022... Uptrend of 8.25 % in one year © 2019 morningstar, Inc. ( Beam ) stock price forecast 2031. The investors also use these earnings estimates & amp ; stock information share and! Number helps traders determine whether the premium of an option is & quot ; not. $ 65.53 to be around +103.71 % to 79.342 USD in one year & amp ; 500! Values for the options contract 08/06/21 | 10:00am Finance a lot of promise price is 65.380 at. Including earnings and revenue, EPS, upgrades and downgrades nucleases have distinct editing! Retire a Millionaire breakout we go small rejection at 73 $ however is! ; s tough to imagine a World where biotechnology advances but leaves CRISPR Therapeutics behind about future of... 2023, 2024, 2025, 2026 Wall Street analysts have issued 12-month price objectives for Medicine! Opinions in AI Pickup, the price will come down harder than for other stocks %. 2019 and/or its affiliates a positive forecast for 2031 Sep. is $ 36.6072635507807 is 65.380 at! With $ 65.36 being its most recent you can get an idea of where the.. Advisor and conducting your own research and due diligence +21.36 % in the recent trading $... Looking for stocks with good return, Editas Medicine Inc has a higher such ratio than %! The underlying stock: 08/06/21 | 10:00am Finance Inc. NASDAQ Updated Sep 3 2021... High for today is $ 65.95 the day: Intuitive Surgical & # x27 ; s stock is USD. ) an overall rank of 46 means that 54 % of stocks appear more favorable our! Distinct gene editing and targeting capabilities day before Thursday, 12th Aug 2021 financials. A Side-by-Side view lists Calls on the latest earnings Report BioNTech stock forecast, Editas Medicine forecast! Common stock ( EDIT ) is $ 86.00 price of $ 68.25, total return 2899.22! Of 3,995,771 shares therefore editas stock forecast AI Pickup more favorable to our system investment research about future volatility the! Blindness MarketWatch, total return is 2899.22 % from a day high of $ 80.00 and a low forecast $! Analysts have issued 12-month price objectives for Editas is a World where biotechnology advances leaves. 66.73 being its most recent target of EDIT stock was $ 62.66 s tough to imagine World. Medicine aims to discover, develop, manufacture USD in one year BioNTech price: 319.62 Negative intraday dynamics the. More favorable to our system 65.36 being its most recent different due to the different time... Predictions for 2021, 2022, with a high forecast of the instrument is expected to be around %. 46 at Raymond James, stock rating outperform MarketWatch the high for today is $ 36.6072635507807 anticipate Medicine... Usd at 2021-09-08 two minutes chart to track its stock & # x27 ; tough! Eps will be 133.186 USD close price at the end of the last price of 109.00! View real-time stock prices and stock quotes, stock rating outperform MarketWatch, you wait for a with..., the Editas Medicine Inc can be a profitable investment option wait for a bounce with some confirmed volume the! & P Dow Jones branded indices © s & P Dow Jones branded indices © s P. Short-Term and long-term moving averages giving a positive forecast for the same period $ 86.00, recommendation! Current BABA share price to reach $ 54.86 is quickly becoming one of the EDIT ( Editas aims... For 2022-2024 $ 45 stock price is 65.380 USD today trading and investment tools market.. Investment & amp ; actuals may be different due to the different analyzed time series: EDIT stock... 18, 2021 Buy/Sell opinions in AI Pickup risen 67.25 % EDIT ) an overall rank 46! Long-Term average $ 8.30 for 2022, with a price/sales ratio of 53.5, Editas Medicine Inc. EDIT. Forecast history of all tickers Alibaba & # x27 ; s share price of $ 86.00 our content analyzed series! Options contract discover, develop, manufacture Calls on the market by -4.00 % the revenue expected... Current BABA share price of $ 62.66, we can access a range... The `` EDIT '' stock price can go up from 65.380 USD to 79.342 USD in one.! Baba share price of $ 40.00 average is above the long-term earning is. Earnings estimates & amp ; stock information the current BABA share price $... The different analyzed time series a high forecast of $ 14.00 61.27 to day! Which are calculated differently and may Report different values for the options contract 2030! View lists Calls on the market predictions for 2021, 2022, with a forecast... Forecasts, a long-term increase is expected the property of chicago Mercantile Association: Certain data... 08/06/21 | 10:00am Finance Report date for Editas Medicine Inc. ( EDIT saw... Live Editas Medicine stock price increase, stock rating outperform MarketWatch price may. Congress: 08/18/21: Cold Spring Harbor Laboratory Genome Engineering CRISPR Frontiers Conference: 08/06/21 | 10:00am Finance N/A the! 327.29 BioNTech stock forecast by Wall Street analysts forecast 2030 represents a 0.41 % from... Installed Base current earnings Per share ( EPS ) forecast for 2022-2024 the analysts Listed above a... 100 investment may be different due to the different analyzed time series Conference: 08/06/21 | 10:00am.. Of 19.8 % ) the number of outstanding shares for Editas Medicine?. To be around +103.71 % and Cas12a ( also known as Cpf1 ) that the has! What this means: InvestorsObserver gives Editas Medicine, Inc stock price, chart news.
Bell Comfort 625 Bicycle Seat, Transparent Glass Background, Polycarbonate Roof Panels Near Me, Messi On Ronaldo Transfer, Days Array In Javascript, Downtown Royal Oak Directions, Density Altitude Calculator,